6. March of Dimes Birth Defects Foundation (2006) March of Dimes Global Report on Birth Defects: The Hidden Toll of Dying and Disabled Children. White Plains, NY: March of Dimes Birth Defects Foundation. Available: http:// www.marchofdimes.com/MOD-Report-PF.pdf. Accessed April 2010. 7. Lejeune J, Gautier M, Turpin R (1959) Etude des chromosomes somatiques de neuf enfants mongoliens. C R Acad Sci 248: 1721–1722. 8. Antonarakis SE, Lyle R, Dermitzakis E, Reymond A, Deutsch S (2004) Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet 5: 725–738. 9. Epstein CJ (2001) Down syndrome (trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease 8th ed. New York: McGraw Hill. pp 1223–1256. 10. Thuline HC, Pueschel SM (1982) Cytogenetics in Down syndrome. In: Pueschel SM, Rynders JE, eds. Down Syndrome: Advances in Biomedicine and the Behavioral Sciences. Cambridge: Ware Press. 133 p. 11. Hook EB, Cross PK, Schreinemachers DM (1983) Chromosomal abnormality rates at amniocentesis and in live-born infants. J A M A 249: 2034–2038. 12. Korenberg JR, Chen XN, Schipper R, Sun Z, Gonsky R, et al. (1994) Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci USA 91: 4997–5001. 13. Lyle R, Bena F, Gagos S, Gehrig C, Lopez G, et al. (2008) Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J of Hum Gen. pp 1–13. 14. Mikkelsen M (1977) Down’s syndrome cytogenetic epidemiology. Hereditas 86: 45–50. 15. Online Mendelian Inheritance in Man - Amyloid Beta A4 Precursor Protein. Available: http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id = 104760. Ac- cessed 24 April 2010. 16. Tanzi RE, Gusella J, Watkins P, Bruns G, George-Hyslop PS, et al. (1987) Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235: 880–884. 17. Beyreuther K, Pollwein P, Multhaup G, Monning U, Konig G, et al. (1993) Regulation and expression of the Alzheimer’s beta/A4 amyloid protein precursor in health, disease, and Down’s syndrome. Ann N Y Acad Sci 695: 91–102. 18. Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropath- ological changes and dementia of Alzheimer’s disease in Down’s syndrome. Ann Neurol 17: 278–282. 19. Lott IT, Head E (2005) Alzheimer disease and Down syndrome: factors in pathogenesis. Neurobiol Aging 26: 383–389. 20. Pearce FH, Rankine R, Ormond AK (1910) Notes on twenty-eight cases of Mongolian Imbeciles: with special reference to their ocular condition. British Medical Journal 2: 186–190. 21. Oliver CA (1891) A clinical study of the ocular symptoms found in the so-called Mongolian type of idiocy. Trans Am Ophthalmol Soc 6: 140–148. 22. Igersheimer J (1951) The Relationship of Lenticular Changes to Mongolism. Trans Am Ophthalmol Soc 49: 595–624. 23. Lowe RF (1949) The eyes in Mongolism. Brit, J Ophthal 33: 131–174. 24. Robb RM, Marchevsky A (1978) Pathology of the Lens in Down’s syndrome. Arch Ophthalmol 96: 1039–1042. 25. Da Cunha RP, Moreira JB (1996) Ocular findings in Down’s syndrome. Am J Ophthalmol 122: 236–244. 26. Creavin AL, Brown RD (2009) Ophthalmic abnormalities in children with Down’s syndrome. J Pediatr Ophthalmol Strabismus 46: 76–82. 27. Kallen B, Mastroiacovo P, Robert E (1996) Major congenital malformations in Down’s syndrome. Am J Med Genet 65: 160–166. 28. Goldstein LE, Muffat JA, Cherny RA, Moir RD, Ericsson MH, et al. (2003) Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer’s disease. Lancet 361: 1258–1265. 29. Armed Forces Institute of Pathology US (1992) Congo red (Bennhold’s) method for amyloid. In: Prophet, Mills, Arrington, Sobin, eds. Laboratory Methods in Histotechnology. Washington, D.C.: American Registry of Pathology. 168 p. 30. Merlini G, Ikeda S, Benson MD, Saraiva MJ, Westermark P, et al. Report of the Nomenclature Committee. In: Skinner M, Berk JL, Connors LH, eds. 2006 Ab in Lens in Down Syndrome November 5-9; Marine Biological Laboratory, Woods Hole, MA. CRC Press (Taylor & Francis Group, LLC). pp xxiii–xxiv. 31. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, et al. (2007) A primer of amyloid nomenclature. Amyloid 14: 179–183. 32. Horwitz J (2000) The function of alpha-crystallin in vision. Semin Cell Dev Biol 11: 53–60. 33. Lowe J, Errington DR, Lennox G, Pike I, Spendlove I, et al. (1992) Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B- crystallin. Neuropathol Appl Neurobiol 18: 341–350. 34. Leverenz JB, Raskind MA (1998) Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis. Exp Neurol 150: 296–304. 35. Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease. Science 235: 877–880. 36. Robakis NK, Wisniewski HM, Jenkins EC, Devine-Gage EA, Houck GE, et al. (1987) Chromosome 21q21 sublocalisation of gene encoding beta-amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzheimer disease and Down syndrome. Lancet 1: 384–385. 37. Oyama F, Cairns N, Shimada H, Oyama R, Titani K, et al. (1994) Down’s syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination. J Neurochem 62: 1062–1066. 38. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, et al. (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38: 24–26. 39. Wavrant-De Vrie`ze F, Crook R, Holmans P, Kehoe P, Owen MJ, et al. (1999) Genetic variability at the amyloid-[beta] precursor protein locus may contribute to the risk of late-onset Alzheimer’s disease. Neurosci Lett 269: 67–70. 40. Zigman WB, Lott IT (2007) Alzheimer’s disease in Down syndrome: neurobiology and risk. Ment Retard Dev Disabil Res Rev 13: 237–246. 41. Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, et al. (1998) Molecular mapping of Alzheimer-type dementia in Down’s syndrome. Ann Neurol 43: 380–383. 42. Schupf N, Sergievsky GH (2002) Genetic and host factors for dementia in Down’s syndrome. Br J Psychiatry 180: 405–410. 43. Cogan DG, Kuwabara T (1962) Pathology of cataracts in mongoloid idiocy. A new concept of the pathogenesis of cataracts of the coronary-cerulean type. Doc Ophthalmol 16: 73–80. 44. Haargaard B, Fledelius HC (2006) Down’s syndrome and early cataract. Br J Ophthalmol 90: 1024–1027. 45. Costello MJ, Johnsen S, Gilliland KO, Freel CD, Fowler WC (2007) Predicted light scattering from particles observed in human age-related nuclear cataracts using mie scattering theory. Invest Ophthalmol Vis Sci 48: 303–312. 46. Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256: 184–185. 47. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297: 353–356. 48. Frederikse PH, Garland D, Zigler JSJ, Piatigorsky J (1996) Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells. J Biol Chem 271: 10169–10174. 49. Frederikse PH, Zigler JS (1998) Presenilin expression in the ocular lens. Curr Eye Res 17: 947–952. 50. Li G, Percontino L, Sun Q, Qazi AS, Frederikse PH (2003) Beta-amyloid secretases and beta-amyloid degrading enzyme expression in lens. Mol Vis 9: 179–183. 51. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, et al. (1996) Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3: 16–32. 52. Hogan MJ, Alvarado JA, Weddell JE (1971) Histology of the Human Eye: An Atlas and Textbook. Philadelphia: W.B. Saunders Company. 687 p. PLoS ONE | www.plosone.org 13 May 2010 | Volume 5 | Issue 5 | e10659